In addition, our studies also found long-term PBM treatment at the early stage of AD was able to reduce Aβ deposition, abnormal tau hyperphosphorylation, neuronal damage, neuronal apoptosis, neuronal degeneration, and protect spine synapses and dendritic spine. Here, MAPT is linked to Alzheimer disease.